Organon & Co.

General ticker "OGN" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $4.6B (TTM average)

Organon & Co. does not follow the US Stock Market performance with the rate: -4.3%.

Estimated limits based on current volatility of 9.0%: low 7.64$, high 9.15$

Factors to consider:

  • Company pays dividends (quarterly): last record date 2025-02-24, amount 0.28$ (Y12.86%)
  • China accounted for 13.2% of revenue in the fiscal year ended 2024-12-31
  • US accounted for 10.5% of revenue in the fiscal year ended 2024-12-31
  • Price in estimated range
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [7.88$, 18.20$]
  • 2025-12-31 to 2026-12-31 estimated range: [8.29$, 18.67$]

Financial Metrics affecting the OGN estimates:

  • Positive: Non-GAAP EPS, $ of 4.11 > 2.19
  • Positive: Operating cash flow per share per price, % of 24.07 > 12.73
  • Negative: Shareholder equity ratio, % of 3.60 <= 22.52
  • Positive: 2.69 < Return on assets ratio (scaled to [-100,100]) of 6.19
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Inventory ratio change, % of -0.25 <= 0

Similar symbols

Short-term OGN quotes

2025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062025-05-072025-05-082025-05-0989101112131415
Price $

Long-term OGN plot with estimates

1015202530Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 202700.51
OGNS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $6,148.00MM $6,263.00MM $6,403.00MM
Operating Expenses $5,026.00MM $4,936.00MM $4,917.00MM
Operating Income $1,122.00MM $1,327.00MM $1,486.00MM
Non-Operating Income $0.00MM $-654.00MM $-679.00MM
Interest Expense $422.00MM $527.00MM $520.00MM
R&D Expense $578.00MM $528.00MM $469.00MM
Income(Loss) $1,122.00MM $673.00MM $807.00MM
Taxes $205.00MM $-350.00MM $-57.00MM
Profit(Loss)* $917.00MM $1,023.00MM $864.00MM
Stockholders Equity $-892.00MM $-70.00MM $472.00MM
Inventory $1,003.00MM $1,315.00MM $1,321.00MM
Assets $10,955.00MM $12,058.00MM $13,101.00MM
Operating Cash Flow $858.00MM $799.00MM $939.00MM
Capital expenditure $427.00MM $261.00MM $175.00MM
Investing Cash Flow $-420.00MM $-260.00MM $-513.00MM
Financing Cash Flow $-433.00MM $-569.00MM $-368.00MM
Earnings Per Share** $3.61 $4.01 $3.36

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.